Joshua Vignolles-Jeong

Joshua Vignolles-Jeong

Auto-generated profile, based on publicly available information

Joshua Vignolles-Jeong

College of Medicine, The Ohio State University, Columbus, Ohio, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GFGuilherme Finger
Guilherme Finger
KWKyle C. Wu
Kyle C. Wu
JVJoshua Vignolles-Jeong
Joshua Vignolles-Jeong
SGSaniya S. Godil
Saniya S. Godil
BMBen G. McGahan
Ben G. McGahan
DPDaniel M Prevedello
Daniel M Prevedello
Among patients with clinical hemifacial spasm (HFS), imaging exams aim to identify the neurovascular conflict (NVC) location. It has been proven that the identification in the preoperative exam increases the rate of surgical success. Despite the description of specific magnetic resonance image (MRI) acquisitions, the site of neurovascular compression is not always visualized. The authors describe a new MRI finding that helps in the diagnosis of HFS, and evaluate the sensitivity, specificity, and interobserver correlation of the described sign. A cross-sectional study including cases of hemifacial spasm treated surgically from 1 August 2011 to 31 July 2021 was performed. The MRIs of the cases were independently evaluated by two experienced neuroradiologists, who were blinded regarding the side of the symptom. The neuroradiologists were assigned to evaluate the MRIs in two separate moments. Primarily, they evaluated whether there was a neurovascular conflict based on the standard technique. Following this initial analysis, the neuroradiologists received a file with the description of the novel sign, named Prevedello Sign (PS). In a second moment, the same neuroradiologists were asked to identify the presence of the PS and, if it was present, to report on which side. A total of 35 patients were included, mostly females (65.7%) with a mean age of 59.02 (+0.48). Since the 35 cases were independently evaluated by two neuroradiologists, a total of 70 reports were included in the analysis. The PS was present in 66 patients (sensitivity of 94.2%, specificity of 91.4% and positive predictive value of 90.9%). When both analyses were performed in parallel (standard plus PS), the sensitivity increased to 99.2%. Based on the findings of this study, the authors conclude that PS is helpful in determining the neurovascular conflict location in patients with HFS. Its presence, combined with the standard evaluation, increases the sensitivity of the MRI to over 99%, without increasing risks of harm to patients or resulting in additional costs.

8 January 2025 in Operative Neurosurgery
Verified
Journal Article
Closed access
JVJoshua Vignolles-Jeong
Joshua Vignolles-Jeong
GFGuilherme Finger
Guilherme Finger
MDMark Damante
Mark Damante
MWMatthieu D. Weber
Matthieu D. Weber
KWKyle C. Wu
Kyle C. Wu
DPDaniel M Prevedello
Daniel M Prevedello
BACKGROUND AND IMPORTANCE: Superior oblique myokymia (SOM) is a rare, acquired aberration of the innervation of the superior oblique, resulting in episodic monocular contraction of the superior oblique muscle characterized by intermittent rotatory eye movement causing diplopia and oscillopsia. Several treatment modalities have been described to treat SOM, including medication and surgical interventions. There is a paucity of reports describing microvascular decompression (MVD) of the trochlear nerve near the root entry zone for the treatment of a neurovascular conflict. The authors describe a case report of a patient who presented with SOM by a supracerebellar infratentorial approach using microscopic and endoscopic visualization. CLINICAL PRESENTATION: A 40-year-old woman presented with an 8-month history of rhythmic contractions of her right orbit with worsening double vision and occasional balance issues. Neuro-ophthalmological evaluation which revealed a right-sided SOM. MRI evaluation demonstrated a potential vascular compression by the superior cerebellar artery near the origin of the trochlear nerve. She underwent MVD by a supracerebellar infratentorial approach using microscopic and endoscopic visualization. The patient experienced resolution of her SOM in the immediate postoperative period and a Trochlear nerve palsy that resolved within 6 months. CONCLUSION: The endoscopic supracerebellar infratentorial approach for MVD of the trochlear nerve is a safe and efficacious approach that provides superior visualization of the trochlear nerve at its origin and in the setting of SOM. This approach shows outcomes comparable with those used in previously described cases.

1 November 2024 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
JVJoshua Vignolles-Jeong
Joshua Vignolles-Jeong
GFGuilherme Finger
Guilherme Finger
DSDivyaam Satija
Divyaam Satija
DKDaniel C. Kreatsoulas
Daniel C. Kreatsoulas
KWKyle C. Wu
Kyle C. Wu
DHDouglas A. Hardesty
Douglas A. Hardesty
OBJECTIVE: The endoscopic endonasal approach (EEA) has evolved into an established technique in skull base surgery. The authors previously examined 1002 EEA procedures and reported factors associated with postoperative complications. Here they report the development and validation of a scoring model based on risk factors to better predict complications following EEA. METHODS: The authors developed an optimized EEA scoring model for predicting postoperative complications as evidenced by the area under the receiver operating characteristic (AUROC) curve using their previously published data in addition to data collected from the subsequent 292 EEA procedures from years 2010–2020. The model was built systematically by evaluating the contributions that different variables had on the overall predictive ability of the model. The aim was to design a model containing as few variables as possible for practicality and to facilitate calculation and use at the bedside. The Clavien-Dindo grading system was used to classify complications into grades I–V based on the level of intervention that was required to manage the complication, with grades III–V considered to be higher-grade (i.e., those requiring reoperation or ICU-level care or death). RESULTS: The authors identified 1294 EEA operations performed between July 2010 and July 2020 that met their inclusion criteria. Higher-grade complications were identified following 135 EEA operations. The variables that were ultimately included in the model were age, BMI, operative time, meningioma, chordoma, expanded intradural approach, and nasoseptal flap use. The final model yielded an acceptable AUROC curve of 0.72 and predicted a stepwise increase in the rate of higher-grade complications as the score increased. A score of 0–2 (low) on the grading system was associated with an average complication rate of 5.1%. A score of 3–5 (medium) was associated with an average complication rate of 12.6%. A score of 6 or above (high) was associated with an average complication rate of 26%. CONCLUSIONS: This EEA complications scoring model accurately categorizes patients into low-, medium-, and high-risk groups with readily obtained variables. A high score in this complications model does not suggest that a patient is ineligible for surgery, but rather highlights the importance of thorough case selection, operating with caution, and appropriate preoperative counseling.

1 February 2024 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Open access
SWSeth B. Wilson
Seth B. Wilson
JWJacob Ward
Jacob Ward
JDJoravar Dhaliwal
Joravar Dhaliwal
KSKatelyn Sette
Katelyn Sette
YAYamenah Ambreen
Yamenah Ambreen
AGAndrew Grossbach
Andrew Grossbach
Objective: Osteodiscitis has been demonstrated to show significant morbidity and mortality. Cultures and CT guided biopsy (CTB) are commonly used diagnosis of osteodiscitis. This study’s purpose is to evaluate the cost burden of CTB and to evaluate how IVDU affects patient management in the setting of osteodiscitis. Methods: Patients admitted for osteodiscitis from 2011–2021 were retrospectively reviewed and stratified into cohorts by CTB status. Additional cohorts were stratified by Intravenous Drug Use (IVDU). Patient demographics, total cost of hospitalization, length of hospitalization, time to biopsy, IVDU status, and other factors were recorded. T-Test, Chi-squared analysis, and ANOVA were used for statistical analysis. Results: Total cost of hospitalization was recorded for 140 patients without CTB and 346 patients with CTB. Average cost of hospitalization for non-CTB was $227,317.86 compared to CTB at $119,799.20 (p < 0.001). Length of stay (LOS) was found to be 18.01 days for non-CTB and 14.07 days for CTB patients (0.00282). When stratified by days until biopsy, patients who had CTB sooner, had significantly reduced cost of hospitalization (p = 0.0003). Patients with IVDU history were significantly younger (p < 0.001) with lower BMI (p < 0.001) and a significantly different clinical profile. There was a significant difference in positive open biopsy when separated by IVDU status (p = 0.025). Conclusion: CTB was associated with significantly reduced cost of hospitalization and LOS compared to non-CTB. IVDU patients with osteodiscitis have significantly different clinical profiles than non-IVDU that may impact diagnosis and treatment. Further work is indicated to elucidate causes of these differences to provide high value care to patients with osteodiscitis.

21 February 2025 in Neurosurgery
Verified
Journal Article
Closed access
MDMark Damante
Mark Damante
JVJoshua Vignolles-Jeong
Joshua Vignolles-Jeong
GFGuilherme Finger
Guilherme Finger
DKDaniel Kreatsoulas
Daniel Kreatsoulas
SCSantino Cua
Santino Cua
JEJ. Bradley Elder
J. Bradley Elder
BACKGROUND AND OBJECTIVE: Maximal safe resection of newly diagnosed glioblastoma (GBM) optimizes clinical outcomes. For patients who receive biopsy or subtotal resection (STR), early repeat resection (ERR) to improve extent of resection can be considered but is controversial. Oncological outcomes of patients undergoing ERR for residual GBM to patients receiving upfront at least near-total resection were compared. METHODS: This case-control study including patients with GBM treated at a single institution identified 3 treatment groups: (1) ERR patients underwent biopsy or STR (<95% cytoreduction), followed by ≥NTR (≥95% cytoreduction) within 8 weeks; (2) control patients underwent upfront ≥NTR; and (3) biopsy with chemoradiation only. ERR and control patients were 1:1 case-control matched by age, performance status, O6-methylguanine-DNA methyltransferase methylation status, isocitrate dehydrogenase mutation status, and completion of standard chemoradiation. Patient demographics, treatments, and oncological outcomes were analyzed. A P-value of <.05 was considered significant. RESULTS: A total of 22 ERR patients (16 biopsies and 6 STR) were identified, and each was matched with a control patient. Baseline patient characteristics at presentation did not differ between matched patients. Time from first surgery to chemoradiation was longer in the ERR cohort (1.8 vs 1.1 months, P < .001). Median overall survival (mOS) (17.7 vs 20.3 months, P = .87) and progression-free survival (5.5 vs 4.5 months, P = .25) did not differ between ERR and control groups, respectively. In the biopsy-only group, mOS was 4.1. Univariate Cox-regression analysis suggested age, failure to complete chemoradiation, isocitrate dehydrogenase-wt, and hemorrhage at presentation were independent predictors of mOS, whereas only age and failure to complete chemoradiation remained independent predictors of mOS after multivariate analysis. Surgical complications were similar between cohorts. CONCLUSION: ERR achieving ≥95% extent of resection within 8 weeks of initial surgery results in similar oncological outcomes to upfront ≥NTR in a case-control–matched analysis despite delayed initiation in chemoradiation for the ERR cohort.

20 February 2024 in Operative Neurosurgery
Verified
Journal Article
Closed access
JVJoshua Vignolles-Jeong
Joshua Vignolles-Jeong
GFGuilherme Finger
Guilherme Finger
SMStephen T. Magill
Stephen T. Magill
BMBen G. McGahan
Ben G. McGahan
KWKyle C. Wu
Kyle C. Wu
DPDaniel M. Prevedello
Daniel M. Prevedello
Roached through a craniotomy and microsurgical resection.1-4 The supraorbital keyhole approach is a minimally invasive technique that can be used with minimal retraction of the brain and limited craniotomy while establishing a surgical field comparable with what can be achieved using traditional transcranial approaches. In this video, we describe the case of a 54-year-old man who underwent a supraorbital eyebrow approach for translamina terminalis resection of papillary thyroid carcinoma metastasis to the third ventricle. A gross total resection was achieved. The results achieved in our series are comparable with previously published reports of patients who underwent surgical resection of metastatic lesions involving the third ventricle.5-11 The patient consented to the procedure and to the publication of his image....